CLEC4D and Sepsis: scGPS2, which involved ARG1-CCR7, IRF6-HP, JAM3-PIK3AP1, and TLR9-CLEC4D, demonstrated superior performance in distinguishing sepsis from normal samples across NGS and microarray platforms.